Project/Area Number |
07042006
|
Research Category |
Grant-in-Aid for international Scientific Research
|
Allocation Type | Single-year Grants |
Section | Special Cancer Research |
Research Field |
Obstetrics and gynecology
|
Research Institution | Kyushu University |
Principal Investigator |
WAKE Norio Kyushu Univ., Medical institute of Bioregulation, Professor, 生体防御医学研究所, 教授 (50158606)
|
Co-Investigator(Kenkyū-buntansha) |
SHAHIB M.Nurhalim Padjadjaran University, Hansan Sadikin Hospital, Department of Obstetrics & Gyne, 産婦人科学講座, 講師
BRATAKOESOEM ディナン エス インドネシアパジャジャラン医科大学, 産婦人科学講座, 講師
MARTAADISOEB ジャンハー インドネシアパジャジャラン医科大学, 産婦人科学講座, 教授
KATO Hidenori Kyushu Univ., Medical institute of Bioregulation, Assistant Professor, 生体防御医学研究所, 講師 (60214392)
ARIMA Takahiro Kyushu Univ., Medical institute of Bioregulation, Lecturer, 生体防御医学研究所, 助手 (80253532)
MARTAADISOEBRATA Djamhoe Padjadjaran University, Hansan Sadikin Hospital, Department of Obstetrics & Gyne
BRATAKOESOEMA Dinan.S. Padjadjaran University, Hansan Sadikin Hospital, Department of Obstetrics & Gyne
RATAKOESOEMA デイナン エス パジャジャラン医学大学, 産婦人科学講座, 講師
HERAN Susant パジャジャラン医学大学, 産婦人科学講座, 講師
DJAMHOER Mar パジャジャラン医学大学, 産婦人科学講座, 教授
加藤 聖子 九州大学, 生体防御医学研究所, 助手 (10253527)
西田 純一 九州大学, 生体防御医学研究所, 助手 (40264113)
|
Project Period (FY) |
1995 – 1997
|
Project Status |
Completed (Fiscal Year 1997)
|
Budget Amount *help |
¥7,800,000 (Direct Cost: ¥7,800,000)
Fiscal Year 1997: ¥2,600,000 (Direct Cost: ¥2,600,000)
Fiscal Year 1996: ¥2,600,000 (Direct Cost: ¥2,600,000)
Fiscal Year 1995: ¥2,600,000 (Direct Cost: ¥2,600,000)
|
Keywords | Complete mole / Choriocarcinoma / Genetic origin / genome imprinting / IGF2-H19 / microcell fusion / tumor suppressor gene (s) / Chromosome7 / 両側アリルの欠失 / 共通欠失領域 / IGF2 / H19 / インプリンティング / 胞状奇胎 / 絨毛 |
Research Abstract |
We investigated 1. genetic origin of choriocarcinoma, 2. association of IGF2 and H19 imprinting with choriocarcinoma and 3. location of tumor suppressor gene (s) on human chromosome 7.1. The genetic origin of 24 trophoblastic neoplasms was determined by using PCR polymorphisms. Based on pregnancy history, the tumor included 9 postmolar trophoblastic tumors. Androgenetic origin was defined in 8 tumors, and the remaining one might have arisen from a normal fertilization. Six tumors retained genetic features carried by the homozygous complete mole. Two showed PCR polymorphisms compatible with that of the heterozygous complete mole. Our results support the suggestion that of all forms of pregnancy that predispose patients to choriocarcinoma, the most likely is the complete mole. Uniparental or monoallelic transmission of the genome that would render a particular type of tumor suppressor gene susceptible to functional inactivation may correspond to the propensity to malignancy in complete m
… More
ores. 2. We studied IGF2 and H19 expression, and methylation status of H19 in choriocarcinomas. Choriocarcinomas were characterized by a low expression of IGF2 and a high expression of H19. Biallelic expression of IGF2 or H19 was found frequently. Contrary to expectation, enhanced H19 expression was accompanied by hypermethylation of CpG sites over the entire gene region, apparently being at variance with the finding in normal placentae and androgenetic moles. The findings provide the possibility that the mutated promoter is responsible for overcoming transcriptional suppression by CpG methylation in the H19 gene. 3. To determine the chromosome carrying putative tumor suppressor gene (s), a single human chromosome was transferred into choriocarcinoma cells. Microcell-hybrids containing chromosome 7 were suppressed or modulated for tumorigenicity and exhibited altered in vitro growth properties, suggesting that chromosome 7 contains a putative tumor suppressor gene (s) for choriocarcinoma. In addition, we obtained evidence to define a critical region on chromosome 7 that was frequently lost in surgically removed choriocarcinoma tissues and cell lines. Using a panel of microsatellite markers, biallelic deletions were observed, which strongly suggests the presence of a tumor suppressor gene (s) within this critical region. Less
|